Aptula A O, Cronin M T D
School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool L3 3AF, UK.
SAR QSAR Environ Res. 2004 Oct-Dec;15(5-6):399-411. doi: 10.1080/10629360412331297353.
Modelling of QT-prolongation has been performed using data for 19 structurally diverse hERG K+ channel blocking drugs taken from literature. The modelling used hydrophobicity corrected for ionisation (log D) and various 2D and 3D physico-chemical molecular descriptors. Stepwise regression produced a two parameter, interpretable and transparent QSAR with good statistical fit, including log D and the maximum diameter of molecules (Dmax). Two strategies were applied for model validation: (i) a scrambling procedure, i.e., training the total set of 19 chemicals after randomising the hERG K+ channel blocking activity data and (ii) use of external validation sets. Validation of the models showed them to be stable and statistically significant. The effect of molecular size on QT-prolongation side effect is discussed.
已利用从文献中获取的19种结构各异的人乙醚相关基因(hERG)钾通道阻滞剂的数据进行了QT间期延长建模。该建模使用了经电离校正的疏水性(log D)以及各种二维和三维物理化学分子描述符。逐步回归产生了一个具有良好统计拟合度的双参数、可解释且透明的定量构效关系(QSAR),包括log D和分子的最大直径(Dmax)。应用了两种策略进行模型验证:(i)一种加扰程序,即在将hERG钾通道阻滞活性数据随机化后对19种化学物质的整个集合进行训练,以及(ii)使用外部验证集。模型验证表明它们是稳定且具有统计学意义的。讨论了分子大小对QT间期延长副作用的影响。